Spectracure Ab
Clinical trials sponsored by Spectracure Ab, explained in plain language.
-
New laser treatment aims to control recurrent prostate cancer
Disease control Recruiting nowThis study tests a new treatment for men whose prostate cancer has come back after radiation therapy. The treatment uses lasers and a light-sensitive drug to destroy cancer cells while sparing healthy tissue. The goal is to see if it is safe and effective, and to find the best do…
Phase: PHASE1, PHASE2 • Sponsor: SpectraCure AB • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Light therapy offers new hope for prostate cancer patients
Disease control Recruiting nowThis study tests a new treatment for prostate cancer that hasn't spread. It uses a special drug activated by light to destroy cancer cells. About 43 men will take part. The goal is to see if it's safe and effective, with follow-up over 18 months.
Phase: PHASE1, PHASE2 • Sponsor: SpectraCure AB • Aim: Disease control
Last updated May 22, 2026 13:50 UTC